Development of Clarithromycin Sustained-Release Tablets
-
Graphical Abstract
-
Abstract
The purpose is to develop a sustained releas e dosage form of charithromycin(CLM) as hydrogel matrix tablet for using only once daily and evaluate its in vitro re lease characteristics. The formulations were screened acc ording to the re lease prof
-
-